Wisconsin lawmakers have overwhelmingly passed a bipartisan bill, 96-0, that would significantly expand access to breast ...
A blood test for detecting cancer early being developed by the diagnostics firm Grail failed to meet its main goal in a giant ...
Grail said Galleri, its multi-cancer early detection test, failed to meet the primary endpoint of a recent trial. The stock slid 47%, to $54.20, in after-hours trading. Through market close, share ...
Sora Ely, MD, emphasized that national lung cancer screening rates remain below 10%, underscoring the urgent need for greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results